Down-regulation of the sodium/iodide symporter explains131I- induced thyroid stunning

Cancer Research

Volumn 67, Issue 15, 2007, Pages 7512-7517

  Nordén, Madeleine M ^a   Larsson, Fredrik ^a   Tedelind, Sofia ^a   Carlsson, Therese ^a   Lundh, Charlotta ^b   Forssell Aronsson, Eva ^b   Nilsson, Mikael ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COTRANSPORTER; DNA 18S; IODINE 131; MESSENGER RNA; SODIUM IODIDE; SOMATOMEDIN C; THYROTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DOSIMETRY; DOWN REGULATION; GENE EXPRESSION; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; THYROID GLAND; THYROID STUNNING; TRANSPORT KINETICS;

ANIMALS; DOWN-REGULATION; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES; RADIATION INJURIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; SYMPORTERS; THYROID DISEASES; THYROID GLAND; THYROTROPIN;

EID: 34547626412     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0823     Document Type: Article

References (42)

1. Dohan O, De la Vieja A, Paroder V, et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003;24:48-77.
2. Park HM, Park YH, Zhou XH. Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma. Thyroid 1997;7:277-80.
3. Medvedec M. Thyroid stunning in vivo and in vitro. Nucl Med Commun 2005;26:731-5.
4. Kalinyak JE, McDougall IR. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning." Nucl Med Commun 2004;25:883-9.
5. Morris LF, Waxman AD, Braunstein GD. Thyroid stunning. Thyroid 2003;13:333-40.
6. Postgård P, Himmelman J, Lindencrona U, et al. Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells. J Nucl Med 2002;43:828-34.
7. 131I in vitro. J Nucl Med 2007;48:481-6.
8. - symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab1997;82:3331-6.
9. Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 1999;19:2051-60.
10. McDougall IR, Weigel RJ. Recombinant human thyrotropin in the management of thyroid cancer. Curr Opin Oncol 2001;13:39-43.
11. - symporter mRNAs in dog thyroid. Mol Cell Endocrinol 1997;131:195-203.
12. Eng PH, Cardona GR, Fang SL, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999;140:3404-10.
13. Nilsson M, Bjorkman U, Ekholm R, Ericson LE. Iodide transport in primary cultured thyroid follicle cells: evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. Eur J Cell Biol 1990;52:270-81.
14. Ericson LE, Nilsson M. Effects of insulin-like growth factor I on growth, epithelial barrier and iodide transport in polarized pig thyrocyte monolayers. Eur J Endocrinol 1996;135:118-27.
15. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
16. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
17. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
18. - transport in porcine thyroid epithelial cells cultured in bicameral chambers. Nucl Med Biol 2001;28:41-50.
19. Taki K, Kogai T, Kanamoto Y, Hershman JM, Brent GA. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3′,5′-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells. Mol Endocrinol 2002;16:2266-82.
20. Rawson RW, Rall JE, Peacock W. Limitations in the treatment of cancer of the thyroid with radioactive iodine. Trans Assoc Am Physicians 1951;64:179-98.
21. 131I. J Nucl Med 2000;41:1198-202.
22. Sisson JC, Avram AM, Lawson SA, Gauger PG, Doherty GM. The so-called stunning of thyroid tissue. J Nucl Med 2006;47:1406-12.
23. Thiriet C, Hayes JJ. Chromatin in need of a fix: phosphorylation of h2ax connects chromatin to DNA repair. Mol Cell 2005;18:617-22.
24. Tsygankova OM, Saavedra A, Rebhun JF, Quilliam LA, Meinkoth JL. Coordinated regulation of rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Mol Cell Biol 2001;21:1921-9.
25. Chun JT, Di Dato V, D'Andrea B, Zannini M, Di Lauro R. The CRE-like element inside the 5′-upstream region of the rat sodium/iodide symporter gene interacts with diverse classes of b-Zip molecules that regulate transcriptional activities through strong synergy with Pax-8. Mol Endocrinol 2004;18:2817-29.
26. Puppin C, Arturi F, Ferretti E, et al. Transcriptional regulation of human sodium/iodide symporter gene: a role for redox factor-1. Endocrinology 2004;145:1290-3.
27. Fritz G, Grosch S, Tomicic M, Kaina B. APE/Ref-1 and the mammalian response to genotoxic stress. Toxicology 2003;193:67-78.
28. Costamagna E, Garcia B, Santisteban P. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-β repression of the sodium/iodide symporter gene. J Biol Chem 2004;279:3439-46.
29. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003;22:5885-96.
30. Clement S, Refetoff S, Robaye B, Dumont JE, Schurmans S. Low TSH requirement and goiter in transgenic mice overexpressing IGF-I and IGF-I receptor in the thyroid gland. Endocrinology 2001;142:5131-9.
31. Santisteban P, Acebron A, Polycarpou-Schwarz M, Di Lauro R. Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinol 1992;6:1310-7.
32. Ortiz L, Zannini M, Di Lauro R, Santisteban P. Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor I. J Biol Chem 1997;272:23334-9.
33. Yu D, Watanabe H, Shibuya H, Miura M. Redundancy of radioresistant signaling pathways originating from insulin-like growth factor I receptor. J Biol Chem 2003;278:6702-9.
34. Macaulay VM, Salisbury AJ, Bohula EA, et al. Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of ATM kinase. Oncogene 2001;20:4029-40.
35. Perer ES, Madan AK, Shurin A, et al. Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells. J Surg Res 2000;94:1-5.
36. Wen B, Deutsch E, Marangoni E, et al. Tyrphostin Ag 1024 modulates radiosensitivity in human breast cancer cells. Br J Cancer 2001;85:2017-21.
37. Peretz S, Jensen R, Baserga R, Glazer PM. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad Sci U S A 2001;98:1676-81.
38. Shahrabani-Gargir L, Pandita TK, Werner H. Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors sp1 and wt1. Endocrinology 2004;145:5679-87.
39. Heron-Milhavet L, Karas M, Goldsmith CM, Baum BJ, LeRoith D. Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair. J Biol Chem 2001;276:18185-92.
40. Garcia B, Santisteban P. PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Mol Endocrinol 2002;16:342-52.
41. Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000;6:871-8.
42. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 2006;155:495-512.